RNA - Avidity Biosciences, Inc. -  [ ]

Ticker Details
Avidity Biosciences, Inc.
IPO Date: June 12, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $10.21B
Activated in VL: False
Average Daily Range
Avg Daily Range: $0.76 | 3.27%
Avg Daily Range (30 D): $1.16 | 2.54%
Avg Daily Range (90 D): $1.09 | 2.65%
Institutional Daily Volume
Avg Daily Volume: .86M
Avg Daily Volume (30 D): 4.5M
Avg Daily Volume (90 D): 3.25M
Trade Size
Avg Trade Size (Sh.): 80
Avg Trade Size (Sh.) (30 D): 139
Avg Trade Size (Sh.) (90 D): 101
Institutional Trades
Total Institutional Trades: 3,446
Avg Institutional Trade: $3.39M
Avg Institutional Trade (30 D): $4.92M
Avg Institutional Trade (90 D): $4.65M
Avg Institutional Trade Volume: .1M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $4.56M
Avg Closing Trade (30 D): $20.67M
Avg Closing Trade (90 D): $14.74M
Avg Closing Volume: 163.69K
 
News
Jan 31, 2026 @ 5:58 PM
Halper Sadeh LLC Encourages TWO, RNA, CVBF, TBN Sh...
Source: Halper Sadeh Llc
Jan 31, 2026 @ 3:46 AM
$HAREHOLDER ALERT: The M&A Class Action Firm Conti...
Source: Prnewswire
Nov 22, 2025 @ 10:34 AM
Halper Sadeh LLC Encourages WTRG, RNA, TCBX Shareh...
Source: Halper Sadeh Llc
Nov 20, 2025 @ 5:43 PM
Novartis Projects Faster Growth Through 2030 After...
Source: Vandana Singh
Oct 28, 2025 @ 10:58 AM
Novartis Maintains Outlook Even As Generics Bite I...
Source: Vandana Singh
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $-1.27 $-1.21
Diluted EPS $-1.27 $-1.21
Revenue $12.48M $3.85M
Gross Profit
Net Income / Loss $-174.44M $-157.32M
Operating Income / Loss $-188.81M $-171.14M
Cost of Revenue
Net Cash Flow $106.25M $-10.29M
PE Ratio